Troy Bloom

958 total citations
5 papers, 74 citations indexed

About

Troy Bloom is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Troy Bloom has authored 5 papers receiving a total of 74 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Troy Bloom's work include Growth Hormone and Insulin-like Growth Factors (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and HER2/EGFR in Cancer Research (1 paper). Troy Bloom is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and HER2/EGFR in Cancer Research (1 paper). Troy Bloom collaborates with scholars based in United States. Troy Bloom's co-authors include Birgit Schoeberl, Chrystal U. Louis, Victoria Rimkunas, Sergio Iadevaia, Vasileios Askoxylakis, Michael D. Curley, Alexey A. Lugovskoy, Daryl C. Drummond, Akos Czibere and Emily A. Pace and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Troy Bloom

5 papers receiving 74 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Troy Bloom United States 3 43 33 20 13 11 5 74
Tomasz Guszcz Poland 6 31 0.7× 58 1.8× 19 0.9× 8 0.6× 6 0.5× 12 101
S. Liu China 4 47 1.1× 44 1.3× 27 1.4× 12 0.9× 3 0.3× 13 107
Fateme Sheida Iran 5 51 1.2× 56 1.7× 35 1.8× 6 0.5× 5 0.5× 14 141
Su‐Chen Huang United States 4 31 0.7× 39 1.2× 6 0.3× 6 0.5× 13 1.2× 4 81
Sheng Yu United Kingdom 6 24 0.6× 78 2.4× 25 1.3× 7 0.5× 10 0.9× 9 118
Anna Maria Lavecchia Italy 5 23 0.5× 20 0.6× 27 1.4× 6 0.5× 5 0.5× 11 65
Dikla Atias Israel 6 52 1.2× 39 1.2× 22 1.1× 2 0.2× 10 0.9× 10 113
S. Denmeade United States 6 30 0.7× 49 1.5× 41 2.0× 15 1.2× 7 0.6× 13 112
Pradnya Kowtal India 7 28 0.7× 43 1.3× 26 1.3× 2 0.2× 9 0.8× 16 100
Xiaopeng Sun United States 7 79 1.8× 39 1.2× 21 1.1× 6 0.5× 5 0.5× 14 141

Countries citing papers authored by Troy Bloom

Since Specialization
Citations

This map shows the geographic impact of Troy Bloom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy Bloom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy Bloom more than expected).

Fields of papers citing papers by Troy Bloom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy Bloom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy Bloom. The network helps show where Troy Bloom may publish in the future.

Co-authorship network of co-authors of Troy Bloom

This figure shows the co-authorship network connecting the top 25 collaborators of Troy Bloom. A scholar is included among the top collaborators of Troy Bloom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy Bloom. Troy Bloom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Kamoun, Walid S., Elden P. Swindell, Christine Pien, et al.. (2020). Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic. Pharmaceutics. 12(10). 996–996. 11 indexed citations
2.
Curley, Michael D., Sergio Iadevaia, Victoria Rimkunas, et al.. (2019). Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer. Scientific Reports. 9(1). 16832–16832. 17 indexed citations
3.
Pace, Emily A., Sharlene Adams, Michael D. Curley, et al.. (2018). Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. Clinical Cancer Research. 24(12). 2873–2885. 44 indexed citations
4.
5.
Bloom, Troy, et al.. (2010). Use of KI67 and geminin expression to better define the proliferation status of invasive breast cancer.. Journal of Clinical Oncology. 28(15_suppl). e21037–e21037. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomasz Guszcz Breakdown of academic impact, for papers by S. Liu Breakdown of academic impact, for papers by Fateme Sheida Breakdown of academic impact, for papers by Su‐Chen Huang Breakdown of academic impact, for papers by Sheng Yu Breakdown of academic impact, for papers by Anna Maria Lavecchia Breakdown of academic impact, for papers by Dikla Atias Breakdown of academic impact, for papers by S. Denmeade Breakdown of academic impact, for papers by Pradnya Kowtal Breakdown of academic impact, for papers by Xiaopeng Sun
Rankless by CCL
2026